Showing 1-10 of 2501 results for "".
- Mathias Basner, MD, PhD, MSchttps://practicalneurology.com/profiles/mathias-basner-md-phd-msc/7ZBpeR/
About the Cover Artist: Purple Phoenix by Denis Ducreux, MD, PhD
https://practicalneurology.com/diseases-diagnoses/imaging-testing/about-the-cover-artist-purple-phoenix-by-denis-ducreux-md-phd/56388/Dr. Ducreux’s artwork originates in diffusion-based MRI studies that reveal the organization of white matter pathways.Seeking Breakthroughs: The Physician Perspective
https://practicalneurology.com/columns/practice-management/the-physician-perspective/30193/A roundtable discussion with Claudia A. Chiriboga, MD, MPH; Jeffrey L. Cummings, MD, ScD; and Nir Lipsman, MD, PhDMonoclonal Antibody Studies
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/monoclonal-antibody-studies/30233/An Interview with Rachelle S. Doody, MD, PhDYoung-Onset ALS: Diagnosis and Research
https://practicalneurology.com/diseases-diagnoses/neuromuscular/young-onset-als-diagnosis-and-research/30098/In this episode, Gwen Petersen discusses her long journey to receiving an ALS diagnosis at age 32, her contributions to a Cytokinetics book project, and the importance of clinical trial participation. We are also joined by Merit Cudkowicz, MD, MSc, Head of the Department of Neurology, Chief of NeuroMedication-Overuse Headache
https://practicalneurology.com/diseases-diagnoses/headache-pain/medication-overuse-headache/30281/Questions and answers from Nina Tsakadze, MD, PhD; Natasha Antonovich; PharmD; and Fabian Rossi, MDELEVATE (Qulipta for Prophylaxis of Migraine in Participants Who Failed Previous Oral Prophylactic Treatments; NCT04740827)
https://practicalneurology.com/programs/practical-neurology/elevate-qulipta-for-prophylaxis-of-migraine-in-participants-who-failed-previous-oral-prophylactic-treatments-nct04740827/31255/Patricia Pozo-Rosich, MD, PhD, Headache Specialist from the Vall d’Hebron University Hospital in Barcelona, Spain, provides an overview of the ELEVATE clinical trial.Seeking Breakthroughs: The Startup Perspective
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/the-startup-perspective/30194/A roundtable discussion with Chase Spurlock, PhD, IQuity; Michal Izrael, PhD, Kadimastem Ltd; Kevin Hrusovsky, Quanterix; and J. Michael Ryan, MD, Rodin TherapeuticsSeeking Breakthroughs: The Industry Perspective
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/the-industry-perspective/30192/A roundtable discussion with Gregory Went, PhD, Adamas Pharmaceuticals; Lynn Kramer, MD, Eisai; Paulo Fontoura, MD, PhD, Genentech/Roche; Justin Gover, BSc, MBA, GW Pharmaceuticals; Marc Kamin, MD, SK Life Sciences; and Mike Davis, BSc, MBA, UCBFactors Influencing the Selection of CSF Tests for Alzheimer Disease
https://practicalneurology.com/videos/neurology-in-motion/factors-influencing-the-selection-of-csf-tests-for-alzheimer-disease/35726/Suzanne Schindler, MD, PhD, Associate Professor of Neurology at Washington University School of Medicine in St. Louis, discusses key factors influencing the selection of cerebrospinal fluid tests for Alzheimer disease.
- Prev
- Next